联合治疗公司 UTHR

Martine Rothblatt, Ph.D., J.D., M.B.A., Career Highlights: United Therapeutics - Founder, Chairperson & CEO (1996-present); SiriusXM - Founder. Other Professional Experience and Achievements: Author: Your Life or Mine: How Geoethics Can Resolve the Conflict Between Private and Public Interests in Xenotransplantation (anticipated the need both for global virus bio-surveillance and a greatly expanded supply of transplantable organs) and Virtually Human (AI ethics and human-machine issues)Author: Your Life or Mine: How Geoethics Can Resolve the Conflict Between Private and Public Interests in Xenotransplantation (anticipated the need both for global virus bio-surveillance and a greatly expanded supply of transplantable organs) and Virtually Human (AI ethics and human-machine issues); Co-inventor of 10 U.S. patents (additional patents pending); UCLA Medal (2018); Benjamin Franklin Medal for Distinguished Achievement in the Sciences (2023); National Business Aviation Association Meritorious Service to Aviation Award (2021); No. 8 on Forbes' inaugural Innovator 250 List, recognizing the 250 living Americans who best embody the nation's creative spirit. (2026); Member of National Academy of Engineering, among the highest professional distinctions accorded to an engineer (2026). Other Current Public Company Boards: BETA Technologies, Inc. Education: B.S., Communications, M.B.A., and J.D., University of California, Los Angeles; Ph.D., Medical Ethics, University of London.

Mr. Benkowitz joined United Therapeutics in 2011 as our Executive Vice President, Organizational Development, and was promoted to President and Chief Operating Officer in 2016. He is responsible for all of our sales, marketing, market access, patient relations, manufacturing, medical affairs, and corporate compliance activities, most company-wide administrative functions, including human resources and information technology, many of our business development efforts, and several of our key business alliances and partnerships.

Mr. Edgemond joined United Therapeutics in January 2013 as Treasurer and Vice President, Strategic Financial Planning. Mr. Edgemond was promoted to Chief Financial Officer and Treasurer in March 2015. Prior to joining United Therapeutics, he was Vice President, Corporate Controller, and Treasurer of Clark Construction Group from 2008 through January 2013. He also served in a variety of roles at The Corporate Executive Board Company from 1998 to 2008, including as Executive Director, Finance from 2005 to 2008. He began his career as a public accountant at KPMG Peat Marwick LLP, from 1990 through 1998, where he served in a variety of roles, including as a Senior Manager prior to his departure.

Mr. Mahon has served as General Counsel and Corporate Secretary of United Therapeutics since its inception in 1996. In 2001, Mr. Mahon joined United Therapeutics full-time as Senior Vice President, General Counsel and Corporate Secretary. In 2003, Mr. Mahon was promoted to Executive Vice President, General Counsel, and Corporate Secretary. Prior to 2001, he served United Therapeutics, beginning with its formation in 1996, in his capacity as principal and managing partner of a law firm specializing in technology and media law.

Ms. Nilda Mesa, J.D., Career Highlights: New York City Mayor's Office - Director, Mayor's Office of Sustainability; led OneNYC, the pathbreaking long-term sustainability plan for the city and oversaw programs in climate, energy, sustainability, air quality and public health, waste, green buildings, transportation, public education, and other initiatives (2014-2016). Columbia University - Adjunct Professor, School of International and Public Affairs (2016-2025); Director, Urban Sustainability and Equity Planning Program (2018-2025); Chief Administrative Officer at the Columbia Journalism School (2012-2014). Other Professional Experience and Achievements: Environmental leadership roles at the White House Council on Environmental Quality, U.S. Air Force, U.S. Environmental Protection Agency, and California Attorney General's Office and the practice of law in the private and public sectors; Visiting Professor and Lecturer, Paris School of International Affairs, SciencesPo (2018-2021); Co-author, Collaborating for Climate Resilience (2021); contributor, Smarter New York City (2019).

Mr. Christopher Causey,M.B.A., Career Highlights: Causey Consortium, professional services organization providing business strategy and marketing counsel to the healthcare industry - Principal (2002-2021); Definity Health Incorporated, a consumer-driven health plan operator - Chief Marketing Officer (2001-2002); Allina Health System, a healthcare system based in Minneapolis, Minnesota - Vice President, Marketing and Communications (1997-2000). Other Professional Experience and Achievements: Board of Trustees of The?College of Wooster (2015-present); Member, Board of Directors, Data Sciences International, Inc. (2008-2013). Education: B.A., Psychology, College of Wooster; M.B.A., George Washington University.

Dr. Judy D. Olian, PhD, Career Highlights: Quinnipiac University - President (2018-2025); President Emerita (2025-present). UCLA Anderson School of Management - Dean; John E. Anderson Chair in Management (2006-2018); Pennsylvania State University - Dean and Professor, Smeal College of Business Administration (2001-2006). Other Professional Experience and Achievements: Advisory boards: U.S. Studies Centre (University of Sydney); Peking University Business School; Connecticut Governor's Workforce Council; Business-Higher Education Forum; New Haven Promise; Catalyst; Co-Chair, AdvanceCT (2024-present); Board Member, Hartford Healthcare (2022-present) and Wisconsin Alumni Research Foundation (2025-present). Other Current Public Company Boards: Ares Management; Mattel, Inc. Education: B.S., Psychology, Hebrew University of Jerusalem; M.S., Industrial Relations, University of Wisconsin-Madison; Ph.D., Industrial Relations, University of Wisconsin-Madison.

Mr. Raymond C. Kurzweil, Career Highlights: Kurzweil Technologies, Inc., a technology development firm - Chief Executive Officer (1995-present); Beyond Imagination, a humanoid robotics company - Chief AI Officer (2025-present); Co-Founder (2018). Google - Principal Researcher and AI Visionary (2023-2025); Director of Engineering (2013-2023). Other Professional Experience and Achievements: Inducted into the National Inventors Hall of Fame (2002); Recipient of the National Medal of Technology, MIT Lemelson Prize, Grammy Award, 21 honorary doctorates, and honors from three U.S. presidents; Previously served as a member of the boards of directors of Inforte Corp. and Medical Manager Corporation, both of which were publicly traded. Education: B.S., Computer Science and Literature, Massachusetts Institute of Technology.

On July 22, 2026, the Board of Directors of United Therapeutics Corporation appointed Victor Dzau, M.D., to serve as a member of the Board. Dr. Dzau recently completed a 12-year tenure as President of the National Academy of Medicine (NAM) and formerly served as Chancellor for Health Affairs at Duke University, President and CEO of the Duke University Health System, and Chairman of Medicine at Harvard and Stanford Universities. His term with NAM expired at the end of June 2026, and in July 2026 he returned to Duke University as James B. Duke Distinguished Professor of Medicine, Chancellor Emeritus for Health Affairs, and Director of the Mandel Center. He also serves as Co-Chair of the G20 High-Level Independent Panel on Financing Pandemic Preparedness and Response.